← Back to Clinical Trials
Recruiting NCT06466707

NCT06466707 Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06466707
Status Recruiting
Phase
Sponsor University Ghent
Condition Microbial Colonization
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-06-04
Primary Completion 2028-05-31

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Collection of microbiome samples

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-06-04 with a primary completion date of 2028-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Large numbers of micro-organisms (especially bacteria) live in and on human bodies and have a very important function for the health. These microorganisms are called 'the microbiota'. They aid in the digestion of food, ensure the production of certain vitamins, and are very important for the development and regulation of the immune system. In many diseases (including Crohn's disease, arthritis, obesity, diabetes and cancer), a disruption of microbial composition is observed. There are indications that a disruption of the microbiome can contribute to the development of inflammatory diseases and cancer, but the underlying processes are not sufficiently understood. To understand the mechanisms underlying these disease processes, fundamental research is conducted at Ghent University. Stool, skin, oral and vaginal samples from various origins are examined, e.g. from people from indigenous tribes with a traditional lifestyle. It is important that these samples can be compared with microbiome samples from healthy Western (West-European) controls. In this study, the investigators want to build up a collection of samples from healthy donors between the ages of 2 and 70, with the exception of vaginal samples collected from women between the ages of 18 and 45. The samples will form the basis for further fundamental and functional research into microbiota-host interactions at Ghent University.

Eligibility Criteria

Inclusion Criteria: * Healthy * Age between 2 and 70 years old * Dutch speaking * West-European origin Exclusion Criteria: * Diagnosis of chronic disease (such as osteoarthritis, rheumatoid arthritis, diabetes, Crohn's disease, inflammatory bowel disease (IBD), asthma, COPD, etc.) * Antibiotics taken within 3 months before sampling

Contact & Investigator

Central Contact

Lars Vereecke, PhD

✉ Lars.Vereecke@UGent.be

📞 09/332.64.04

Principal Investigator

Bruno Verhasselt, MD-PhD

PRINCIPAL INVESTIGATOR

University Ghent

Frequently Asked Questions

Who can join the NCT06466707 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 70 Years, studying Microbial Colonization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06466707 currently recruiting?

Yes, NCT06466707 is actively recruiting participants. Contact the research team at Lars.Vereecke@UGent.be for enrollment information.

Where is the NCT06466707 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT06466707 clinical trial?

NCT06466707 is sponsored by University Ghent. The principal investigator is Bruno Verhasselt, MD-PhD at University Ghent. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology